AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
Human papillomavirus infection, risk for subsequent development of cervical neoplasia and associated population attributable fraction
Authors: Lehtinen, M Luukkaala, T Wallin, KL Paavonen, J Thoresen, S Dillner, J Hakama, M
Citation: M. Lehtinen et al., Human papillomavirus infection, risk for subsequent development of cervical neoplasia and associated population attributable fraction, J CLIN VIRO, 22(1), 2001, pp. 117-124
Efficacy of preventive human papillomavirus vaccination
Authors: Lehtinen, M Paavonen, J
Citation: M. Lehtinen et J. Paavonen, Efficacy of preventive human papillomavirus vaccination, INT J STD A, 12(12), 2001, pp. 771-776
Agonists calcitonin, corticotropin-releasing hormone, and vasoactive intestinal peptide, but not prostaglandins or beta-adrenergic agonists, elevate cyclic adenosine monophosphate levels in oligodendroglial cells
Authors: Wiemelt, AP Lehtinen, M McMorris, FA
Citation: Ap. Wiemelt et al., Agonists calcitonin, corticotropin-releasing hormone, and vasoactive intestinal peptide, but not prostaglandins or beta-adrenergic agonists, elevate cyclic adenosine monophosphate levels in oligodendroglial cells, J NEUROSC R, 65(2), 2001, pp. 165-172
Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma
Authors: Anttila, T Saikku, P Koskela, P Bloigu, A Dillner, J Ikaheimo, I Jellum, E Lehtinen, M Lenner, P Hakulinen, T Narvanen, A Pukkala, E Thoresen, S Youngman, L Paavonen, J
Citation: T. Anttila et al., Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma, J AM MED A, 285(1), 2001, pp. 47-51
Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck - Reply
Authors: Mork, J Lehtinen, M Dillner, J
Citation: J. Mork et al., Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck - Reply, N ENG J MED, 345(5), 2001, pp. 377-377
Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck.
Authors: Mork, J Lie, AK Glattre, E Clark, S Hallmans, G Jellum, E Koskela, P Moller, B Pukkala, E Schiller, JT Youngman, L Lehtinen, M Dillner, J
Citation: J. Mork et al., Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck., N ENG J MED, 344(15), 2001, pp. 1125-1131
Poor antibody response against human papillomavirus in adult-onset laryngeal papillomatosis
Authors: Aaltonen, LM Auvinen, E Dillner, J Lehtinen, M Paavonen, J Rihkanen, H Vaher, A
Citation: Lm. Aaltonen et al., Poor antibody response against human papillomavirus in adult-onset laryngeal papillomatosis, J MED MICRO, 50(5), 2001, pp. 468-471
Prerequisites for human papillomavirus vaccine trial: results of feasibility studies
Authors: Paavonen, J Halttunen, M Hansson, BG Nieminen, P Rostila, T Lehtinen, M
Citation: J. Paavonen et al., Prerequisites for human papillomavirus vaccine trial: results of feasibility studies, J CLIN VIRO, 19(1-2), 2000, pp. 25-30
Prospects for phase III-IVHPV vaccination trials in the Nordic countries and in Estonia
Authors: Lehtinen, M Kibur, M Luostarinen, T Anttila, A Pukkala, E
Citation: M. Lehtinen et al., Prospects for phase III-IVHPV vaccination trials in the Nordic countries and in Estonia, J CLIN VIRO, 19(1-2), 2000, pp. 113-122
Vaccinating women against premature death - Structured general discussion,Helsinki, 10 January 2000, chairpersons: Matti Lehtinen (ML) and Maurice Hilleman (MH)
Authors: Lehtinen, M Hilleman, M
Citation: M. Lehtinen et M. Hilleman, Vaccinating women against premature death - Structured general discussion,Helsinki, 10 January 2000, chairpersons: Matti Lehtinen (ML) and Maurice Hilleman (MH), J CLIN VIRO, 19(1-2), 2000, pp. 123-133
Proceedings of the HPV vaccination workshop: Vaccinating women against premature death
Authors: Lehtinen, M
Citation: M. Lehtinen, Proceedings of the HPV vaccination workshop: Vaccinating women against premature death, J CLIN VIRO, 19(1-2), 2000, pp. VIII-IX
Attack rates of human papillomavirus type 16 and cervical neoplasia in primiparous women and field trial designs for HPV16 vaccination
Authors: Kibur, M af Geijerstamm, V Pukkala, E Koskela, P Luostarinen, T Paavonen, J Schiller, J Wang, Z Dillner, J Lehtinen, M
Citation: M. Kibur et al., Attack rates of human papillomavirus type 16 and cervical neoplasia in primiparous women and field trial designs for HPV16 vaccination, SEX TRANS I, 76(1), 2000, pp. 13-17
Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery
Authors: Mosorin, M Surcel, HM Laurila, A Lehtinen, M Karttunen, R Juvonen, J Paavonen, J Morrison, RP Saikku, P Juvonen, T
Citation: M. Mosorin et al., Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery, ART THROM V, 20(4), 2000, pp. 1061-1067
Joint effect of HPV16 with Chlamydia trachomatis and smoking on risk of cervical cancer: antagonism or misclassification (Nordic countries)
Authors: Hakama, M Luostarinen, T Hallmans, G Jellum, E Koskela, P Lehtinen, M Thoresen, S Youngman, L Hakulinen, T
Citation: M. Hakama et al., Joint effect of HPV16 with Chlamydia trachomatis and smoking on risk of cervical cancer: antagonism or misclassification (Nordic countries), CANC CAUSE, 11(9), 2000, pp. 783-790
Acute leukaemia and other secondary neoplasms in patients treated with conventional chemotherapy for multiple myeloma: a Finnish Leukaemia Group study
Authors: Oivanen, T Ala-Harja, K Almqvist, A Apajalahti, J Elonen, E Hallman, H Hanninen, A Ilvonen, M Isomaa, B Jouppila, J Jarvenpaa, E Jarventie, G Kilpi, H Koistinen, P Koistinen, S Koivisto, AM Koivunen, E Korpi, E Katka, K Kaariainen, M Lahtinen, R Laitinen, A Lehtinen, M Makela, H Nylanden, P Nyman, D Palva, I Pelliniemi, TT Pulli, T Rajamaki, A Rauhala, A Remes, K Rosengard, S Ruutu, T Soininen, K Tiilikainen, J Timonen, T Waris, E Vilpo, J Volin, L
Citation: T. Oivanen et al., Acute leukaemia and other secondary neoplasms in patients treated with conventional chemotherapy for multiple myeloma: a Finnish Leukaemia Group study, EUR J HAEMA, 65(2), 2000, pp. 123-127
Chlamydia trachomatis reactive T lymphocytes from upper genital tract tissue specimens
Authors: Kinnunen, A Molander, P Laurila, A Rantala, I Morrison, R Lehtinen, M Karttunen, R Tiitinen, A Paavonen, J Surcel, HM
Citation: A. Kinnunen et al., Chlamydia trachomatis reactive T lymphocytes from upper genital tract tissue specimens, HUM REPR, 15(7), 2000, pp. 1484-1489
Seropositivity to multiple sexually transmitted infections is not common
Authors: Kibur, M Koskela, P Dillner, J Leinikki, P Saikku, P Lehtinen, M Hakama, M
Citation: M. Kibur et al., Seropositivity to multiple sexually transmitted infections is not common, SEX TRA DIS, 27(8), 2000, pp. 425-430
World-system position, national political characteristics and economic development outcomes
Authors: Kick, EL Davis, BL Lehtinen, M Burns, TJ
Citation: El. Kick et al., World-system position, national political characteristics and economic development outcomes, J POLIT MIL, 28(1), 2000, pp. 131-155
Type specificity and significance of different isotypes of serum antibodies to human papillomavirus capsids
Authors: Wang, ZH Kjellberg, L Abdalla, H Wiklund, F Eklund, C Knekt, P Lehtinen, M Kallings, I Lenner, P Hallmans, G Mahlck, CG Wadell, G Schiller, J Dillner, J
Citation: Zh. Wang et al., Type specificity and significance of different isotypes of serum antibodies to human papillomavirus capsids, J INFEC DIS, 181(2), 2000, pp. 456-462
Family and economic growth - A world-system approach and a cross-national analysis
Authors: Kick, E Davis, B Lehtinen, M Wang, LY
Citation: E. Kick et al., Family and economic growth - A world-system approach and a cross-national analysis, INT J COMP, 41(2), 2000, pp. 225-244
Chlamydia trachomatis infection as a risk factor for invasive cervical cancer
Authors: Koskela, P Anttila, T Bjorge, T Brunsvig, A Dillner, J Hakama, M Hakulinen, T Jellum, E Lehtinen, M Lenner, P Luostarinen, T Pukkala, E Saikku, P Thoresen, S Youngman, L Paavonen, J
Citation: P. Koskela et al., Chlamydia trachomatis infection as a risk factor for invasive cervical cancer, INT J CANC, 85(1), 2000, pp. 35-39
Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy
Authors: Arvaja, M Lehtinen, M Koskela, P Lappalainen, M Paavonen, J Vesikari, T
Citation: M. Arvaja et al., Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy, SEX TRANS I, 75(3), 1999, pp. 168-171
Interactions between human papillomavirus and other sexually transmitted agents in the etiology of cervical cancer
Authors: Paavonen, J Lehtinen, M
Citation: J. Paavonen et M. Lehtinen, Interactions between human papillomavirus and other sexually transmitted agents in the etiology of cervical cancer, CURR OPIN I, 12(1), 1999, pp. 67-71
Low levels of serum vitamins A and E in blood and subsequent risk for cervical cancer: Interaction with HPV seropositivity
Authors: Lehtinen, M Luostarinen, T Youngman, LD Anttila, T Dillner, J Hakulinen, T Koskela, P Lenner, P Hallmans, G
Citation: M. Lehtinen et al., Low levels of serum vitamins A and E in blood and subsequent risk for cervical cancer: Interaction with HPV seropositivity, NUTR CANCER, 34(2), 1999, pp. 229-234
No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11
Authors: Luostarinen, T af Geijersstam, V Bjorge, T Eklund, C Hakama, M Hakulinen, T Jellum, E Koskela, P Paavonen, J Pukkala, E Schiller, JT Thoresen, S Youngman, LD Dillner, J Lehtinen, M
Citation: T. Luostarinen et al., No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11, INT J CANC, 80(6), 1999, pp. 818-822
Risultati: 1-25 | 26-26